DART and laboratory monitoring of HIV treatment
Lancet
.
2010 Mar 20;375(9719):979; author reply 979-80.
doi: 10.1016/S0140-6736(10)60430-8.
Authors
Shilpa Sayana
,
Rishi Manchanda
,
Homayoon Khanlou
,
Jorge Saavedra
,
Peter Reis
,
Michael Weinstein
PMID:
20304235
DOI:
10.1016/S0140-6736(10)60430-8
No abstract available
Publication types
Comment
Letter
MeSH terms
Africa
Anti-Retroviral Agents / therapeutic use*
Drug Monitoring
HIV Infections / drug therapy*
HIV Infections / mortality
Humans
Randomized Controlled Trials as Topic
Survival Rate
Substances
Anti-Retroviral Agents